4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050564
Chief Financial Officer bought 2,000 shares at $36.80 ($73,600)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2018-07-27 | Purchase | +2,000 | $36.80 | $73,600 | 47,000 | D |
| Open-market purchases · 2,000 sh · avg $36.80 · $73,600 | |||||||
Loading xslF345X03/doc4.xml…